Aspira Women’s Health Inc. (NASDAQ:AWH) Short Interest Up 26.2% in April

Aspira Women’s Health Inc. (NASDAQ:AWH) was the recipient of a large growth in short interest in April. As of April 15th, there was short interest totalling 169,400 shares, a growth of 26.2% from the March 31st total of 134,200 shares. Based on an average daily volume of 27,900 shares, the days-to-cover ratio is presently 6.1 days. Currently, 2.5% of the shares of the stock are sold short.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on AWH. Cantor Fitzgerald reiterated a “neutral” rating and issued a $3.30 price objective on shares of Aspira Women’s Health in a report on Wednesday, April 10th. StockNews.com assumed coverage on Aspira Women’s Health in a report on Saturday. They set a “hold” rating for the company.

Aspira Women’s Health Stock Performance

AWH stock traded up $0.05 during trading on Friday, hitting $3.33. 16,905 shares of the company traded hands, compared to its average volume of 22,147. The firm has a market capitalization of $41.05 million, a PE ratio of -0.28 and a beta of 1.61. Aspira Women’s Health has a 1 year low of $2.31 and a 1 year high of $6.75. The company has a 50-day moving average of $3.58 and a 200-day moving average of $3.99.

Aspira Women’s Health (NASDAQ:AWH) last released its quarterly earnings results on Thursday, March 28th. The company reported ($0.30) EPS for the quarter, beating analysts’ consensus estimates of ($0.39) by $0.09. The business had revenue of $2.13 million during the quarter, compared to analyst estimates of $2.70 million. Aspira Women’s Health had a negative return on equity of 1,099.32% and a negative net margin of 176.74%. Sell-side analysts expect that Aspira Women’s Health will post -1.24 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Northeast Financial Consultants Inc bought a new position in shares of Aspira Women’s Health in the 3rd quarter worth approximately $126,000. Quantum Private Wealth LLC increased its position in Aspira Women’s Health by 76.8% during the 4th quarter. Quantum Private Wealth LLC now owns 50,156 shares of the company’s stock valued at $205,000 after buying an additional 21,788 shares in the last quarter. B. Riley Wealth Advisors Inc. increased its position in Aspira Women’s Health by 39.0% during the 3rd quarter. B. Riley Wealth Advisors Inc. now owns 125,374 shares of the company’s stock valued at $672,000 after buying an additional 35,177 shares in the last quarter. Finally, Perkins Capital Management Inc. bought a new position in Aspira Women’s Health during the 3rd quarter valued at approximately $268,000. Institutional investors own 12.19% of the company’s stock.

Aspira Women’s Health Company Profile

Aspira Women's Health Inc, together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company's products include Ova1, a blood test intended as an aid to further assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker reflex test; and Ova1Plus, a reflex offering.